On November 27, 2024, Melinda Pei, a Director at Rapid Micro Biosystems Inc (RPID, Financial), purchased 20,000 shares of the company. Following this transaction, the insider now owns a total of 34,300 shares. The transaction details can be found in the SEC Filing.
Rapid Micro Biosystems Inc is a company that provides innovative products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and other products. The company's technology is designed to deliver rapid, accurate, and reliable results, enhancing the efficiency and safety of manufacturing processes.
The insider's recent purchase is part of a broader trend within the company. Over the past year, there have been five insider buys and no insider sells, indicating a positive sentiment among the company's insiders.
On the day of the purchase, shares of Rapid Micro Biosystems Inc were trading at $1.05, giving the stock a market cap of $42.608 million. The company's stock is currently trading below its GF Value of $1.53, resulting in a price-to-GF-Value ratio of 0.69. This suggests that the stock is considered a "Possible Value Trap, Think Twice" based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also includes a GuruFocus adjustment factor based on the company's past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
